MedGenome raises USD 47.5 mn in Series E funding led by Maj Invest and Novo Holdings to expand genomics access across India and emerging markets.
Amount Raised
$47.5 Million
Round Type
Series E
BengaluruBiotechnologyHealth CareGeneticsHealth DiagnosticsInvestors
Description
MedGenome has raised USD 47.5 million in a Series E funding round from Maj Invest and existing investor Novo Holdings. The round also included participation from Sofina. This funding will help broaden access to its genomics and integrated diagnostics solutions. It reflects the growing adoption of genomics in personalized healthcare in India and other emerging economies.
Quick answer
MedGenome raised $47.5 Million in a Series E round, dated July 21, 2025. Investors: Sofina, Maj Invest and Novo Holdings. MedGenome is based in Bengaluru, Karnataka, India.
- How much did MedGenome raise?
- MedGenome raised $47.5 Million in a Series E round on July 21, 2025.
- Who invested in MedGenome?
- Sofina, Maj Invest and Novo Holdings are named as investors in this round.
- What does MedGenome do?
- MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome.
- Where is MedGenome based and how big is it?
- MedGenome is based in Bengaluru, Karnataka, India.
- Who are the decision-makers at MedGenome?
- Fundz holds 1 contact at MedGenome. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Health Diagnostics around the same time
Companies in the same sectors as MedGenome that raised within 45 days of this round, from Fundz verified event records.
- QuidelOrtho raised an undisclosed amount (Funding Round) on August 21, 2025.
- Method AI raised $20M (Series A) on August 21, 2025.
- Altera Biosciences raised $1.6M (Pre-Seed) on August 7, 2025.
- Lumos Diagnostics raised $3.7M (Seed) on July 17, 2025.
- Prime Medicine raised $24M (Funding Round) on July 16, 2025.
- Lyrebird Health raised $8.9M (Funding Round) on June 18, 2025.
Who to call at MedGenome, and when
A new round usually means MedGenome is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MedGenome raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MedGenome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MedGenome. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MedGenome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
MedGenome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.